US NIH studies find high response with one dose of H1N1 vaccine - updated
This article was originally published in Scrip
Executive Summary
Early data from US National Institutes of Health-sponsored studies of two A/H1N1 influenza vaccines show a high immunogenic response with only one dose, similar to results seen in vaccine manufacturers' own tests, US government officials announced on September 11th.